Catalog No.:AA0094QJ

1082503-77-2 | [1-(2-Hydroxy-2-methyl-propyl)pyrazol-4-yl]boronic acid pinacol ester

Name: Name:[1-(2-Hydroxy-2-methyl-propyl)pyrazol-4-yl]boronic acid pinacol ester
Brand: AABLOCKS
SKU: AA0094QJ
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

50mg

97%

in stock

$7.00 $5.00

- +

100mg

97%

in stock

$12.00 $8.00

- +

250mg

97%

in stock

$17.00 $12.00

- +

97%

in stock

$66.00 $47.00

- +

97%

in stock

$173.00 $121.00

- +

10g

≥97%

in stock

$249.00 $174.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA0094QJ

Chemical Name:

[1-(2-Hydroxy-2-methyl-propyl)pyrazol-4-yl]boronic acid pinacol ester

CAS Number:

1082503-77-2

Molecular Formula:

C13H23BN2O3

Molecular Weight:

266.1443

MDL Number:

MFCD22378011

SMILES:

CC(Cn1ncc(c1)B1OC(C(O1)(C)C)(C)C)(O)C

Properties

Computed Properties

Complexity:

331

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

Downstream Synthesis Route

558-30-5

269410-08-4

1082503-77-2

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2011/76291,2011,A1Locationinpatent:Page/Pagecolumn160

[2]Ndubaku,ChudiO.;Heffron,TimothyP.;Staben,StevenT.;Baumgardner,Matthew;Blaquiere,Nicole;Bradley,Erin;Bull,Richard;Do,Steven;Dotson,Jennafer;Dudley,Danette;Edgar,KyleA.;Friedman,LoriS.;Goldsmith,Richard;Heald,RobertA.;Kolesnikov,Aleksandr;Lee,Leslie;Lewis,Cristina;Nannini,Michelle;Nonomiya,Jim;Pang,Jodie;Price,Steve;Prior,WeiWei;Salphati,Laurent;Sideris,Steve;Wallin,JefferyJ.;Wang,Lan;Wei,Binqing;Sampath,Deepak;Olivero,AlanG.[JournalofMedicinalChemistry,2013,vol.56,#11,p.4597-4610]

[3]CurrentPatentAssignee:UCB-WO2008/44022,2008,A1Locationinpatent:Page/Pagecolumn35

[4]CurrentPatentAssignee:PFIZERINC-WO2017/70708,2017,A1Locationinpatent:Paragraph00407;00408;00409;00410

[5]CurrentPatentAssignee:SYROSPHARMACEUTICALSINC-WO2018/13867,2018,A1Locationinpatent:Paragraph362

[6]CurrentPatentAssignee:INCYTECORP-US2014/45814,2014,A1Locationinpatent:Paragraph0252;0253

[7]Zhang,Hefeng;Peng,Xia;Dai,Yang;Shao,Jingwei;Ji,Yinchun;Sun,Yiming;Liu,Bo;Cheng,Xu;Ai,Jing;Duan,Wenhu[JournalofMedicinalChemistry,2021,vol.64,#7,p.3956-3975]

[8]CurrentPatentAssignee:CHINESEACADEMYOFSCIENCES;ShanghaiInstituteofMateriaMedica(in:CAS)-EP4029862,2022,A1Locationinpatent:Paragraph0321-0323

[9]CurrentPatentAssignee:CHINESEACADEMYOFSCIENCES;ShanghaiInstituteofMateriaMedica(in:CAS)-EP4029862,2022,A1Locationinpatent:Paragraph0321-0323

[10]CurrentPatentAssignee:CHINESEACADEMYOFSCIENCES;ShanghaiInstituteofMateriaMedica(in:CAS)-EP4029862,2022,A1Locationinpatent:Paragraph0321-0323

[11]CurrentPatentAssignee:CANCERRESEARCHUK;MERCKKGAA-WO2016/41618,2016,A1Locationinpatent:Page/Pagecolumn106-107

[12]CurrentPatentAssignee:BLUEPRINTMEDICINESCORP-US2016/31892,2016,A1Locationinpatent:Paragraph0141-0142

[13]CurrentPatentAssignee:BLUEPRINTMEDICINESCORP-US2017/22206,2017,A1Locationinpatent:Paragraph0227;0228;0229

[14]CurrentPatentAssignee:QUINGDAOHUANGHAIPHARMACEUTICAL-EP3042907,2016,A1Locationinpatent:Paragraph0265;0266

[15]CurrentPatentAssignee:ALMIRALLSA-WO2016/198663,2016,A1Locationinpatent:Page/Pagecolumn66

[16]CurrentPatentAssignee:ALMIRALLSA-WO2017/220431,2017,A1Locationinpatent:Page/Pagecolumn67

[17]CurrentPatentAssignee:ABBISKOTHERAPEUTICSCO.,LTD.;ABBISKOPHARMACEUTICALS-US2020/71302,2020,A1Locationinpatent:Paragraph0143;0154;0155

[18]Locationinpatent:schemeortablePerry,Benjamin;Beevers,Rebekah;Bennett,Gavin;Buckley,George;Crabbe,Tom;Gowers,Lewis;James,Lynwen;Jenkins,Kerry;Lock,Chris;Sabin,Verity;Wright,Sara[BioorganicandMedicinalChemistryLetters,2008,vol.18,#19,p.5299-5302]

[19]CurrentPatentAssignee:ABBOTTLABORATORIESINC-US2010/144783,2010,A1Locationinpatent:Page/Pagecolumn16

[20]CurrentPatentAssignee:MERCK&COINC-WO2010/118207,2010,A1Locationinpatent:Page/Pagecolumn361

[21]CurrentPatentAssignee:ASTELLASPHARMAINC.-WO2010/141406,2010,A2Locationinpatent:Page/Pagecolumn87-88

[22]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2011/54841,2011,A1Locationinpatent:Page/Pagecolumn107-108

[23]CurrentPatentAssignee:ABBVIEINC-US2011/281868,2011,A1Locationinpatent:Page/Pagecolumn21-22

[24]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2012/208798,2012,A1Locationinpatent:Page/Pagecolumn49

[25]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2012/125893,2012,A1Locationinpatent:Page/Pagecolumn210-211

[26]CurrentPatentAssignee:CANCERRESEARCHUK-WO2014/37751,2014,A1Locationinpatent:Paragraph00419

[27]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-US2014/163025,2014,A1Locationinpatent:Paragraph0353;0354

[28]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-WO2014/86712,2014,A1Locationinpatent:Page/Pagecolumn77

[29]CurrentPatentAssignee:JAPANTOBACCOINC-US2015/25120,2015,A1Locationinpatent:Paragraph0174-0176

[30]CurrentPatentAssignee:PFIZERINC-WO2015/92610,2015,A1Locationinpatent:Page/Pagecolumn202;203

[31]CurrentPatentAssignee:SHENZHENLINGFANGBIOTECH-EP3825314,2021,A1Locationinpatent:Paragraph0214

1082503-77-2

1282518-09-5

1282513-48-7

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2011/76292,2011,A1Locationinpatent:Page/Pagecolumn230

1082503-77-2

1300031-98-4

1301197-85-2

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2011/54841,2011,A1Locationinpatent:Page/Pagecolumn177-178

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2012/208798,2012,A1Locationinpatent:Page/Pagecolumn83

130191-91-2

1082503-77-2

1613300-97-2

[1]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-WO2014/86712,2014,A1Locationinpatent:Page/Pagecolumn77;78

269410-08-4

558-42-9

2-methyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propan-2-ol

[1]Patent:WO2016/615,2016,A1.Locationinpatent:Paragraph00664

Literature

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS